Clinical trial
ALA and Prostate Cancer
NCT00309439 · University of Toronto, Other · Unknown status
Key facts
| NCT number | NCT00309439 |
|---|---|
| Title | ALA and Prostate Cancer |
| Official title | Studies of Serum PSA to Help Resolve the Current Implication of Alpha-linolenic Acid (ALA) and Prostate Cancer |
| Lead sponsor | University of Toronto, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Diet Therapy, Prostate Cancer |
| Intervention type | Procedure |
| Interventions | ALA-rich diet |
| First posted | Mar 31, 2006 |
| Last update posted | Jun 13, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: